Microbial adjuvants are essential for the development of T-cell-dependent antibody production, recall T-cell proliferation and interferon-γ production following immunization with protein antigens. Using an adoptive transfer approach, we showed that the adjuvant lipopolysaccharide enhanced the frequency of cells producing interleukin-2, enhanced clonal expansion by antigen-specific CD4 T cells and increased CD86 and interleukin-1α production by antigen-presenting cells. All of these effects were dependent on Toll-like receptor-4 (TLR4) expression by cells other than the antigen-specific CD4 T cells. The ability of lipopolysaccharides to increase the number of antigen-specific CD4 T cells that survive after immunization probably explains the previous finding that antigen-specific proliferation by T cells from normal mice depends on previous exposure to antigen and adjuvant. © 2007 Blackwell Publishing Ltd.
Lipopolysaccharide enhances in vivo interleukin-2 production and proliferation by naive antigen-specific CD4 T cells via a Toll-like receptor 4-dependent mechanism
Costalonga M.
First
;
2007-01-01
Abstract
Microbial adjuvants are essential for the development of T-cell-dependent antibody production, recall T-cell proliferation and interferon-γ production following immunization with protein antigens. Using an adoptive transfer approach, we showed that the adjuvant lipopolysaccharide enhanced the frequency of cells producing interleukin-2, enhanced clonal expansion by antigen-specific CD4 T cells and increased CD86 and interleukin-1α production by antigen-presenting cells. All of these effects were dependent on Toll-like receptor-4 (TLR4) expression by cells other than the antigen-specific CD4 T cells. The ability of lipopolysaccharides to increase the number of antigen-specific CD4 T cells that survive after immunization probably explains the previous finding that antigen-specific proliferation by T cells from normal mice depends on previous exposure to antigen and adjuvant. © 2007 Blackwell Publishing Ltd.| File | Dimensione | Formato | |
|---|---|---|---|
|
imm0122-0124.pdf
Accesso aperto
Descrizione: https://www.ncbi.nlm.nih.gov/pmc/articles/2265990
Tipo di file:
PDF EDITORIALE
Dimensione
639.36 kB
Formato
Adobe PDF
|
639.36 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



